Business description: Wasatch Pharmaceutical, Inc.

Executive Committee: Wasatch Pharmaceutical, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Gary V. Heesch
CEO | Chief Executive Officer | - | 01/11/2010 |
| President | - | 01/11/2010 | |
Robert Meader
SAM | Sales & Marketing | - | 02/11/2010 |
Company details: Wasatch Pharmaceutical, Inc.
Wasatch Pharmaceutical, Inc.
310 East 4500 South
84107, Murray
+

Other Personal Products
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.85% | +0.66% | -6.01% | -0.31% | 356B | ||
| -1.06% | +1.71% | -8.05% | +3.20% | 136B | ||
| -2.09% | +0.30% | +0.98% | +22.60% | 76.04B | ||
| -3.30% | +0.83% | -11.39% | -20.84% | 54.68B | ||
| -2.48% | -0.21% | -6.81% | -23.60% | 37.98B | ||
| -3.13% | -0.81% | -4.39% | -57.66% | 30.55B | ||
| -2.77% | +0.07% | +3.43% | -1.15% | 19.81B | ||
| -1.38% | +2.36% | -28.72% | -33.80% | 19.53B | ||
| +1.09% | +3.54% | +5.43% | +24.56% | 18.45B | ||
| Average | -1.97% | +3.91% | -6.17% | -9.67% | 83.15B | |
| Weighted average by Cap. | -2.14% | +4.01% | -6.10% | -2.65% |

















